It is a pharma private limited company based in Delhi, Delhi, India, established in 2009.
2009 | Delhi, Delhi, India | ActiveVipul Pharma Private Limited, a active private limited company, was established on 16 December 2009 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2009PTC196994. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sonia Kansal (Whole-Time Director), Parvinder Kansal (Whole-Time Director). Past directors included Ashok Garg, Rajinder Gupta, Sonia Kansal. It holds ₹3.00 Cr open charges and ₹6.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No.805, Klj Tower Netaji Subhash Place Pitampura, Delhi, Delhi, 110034.
U24232DL2009PTC196994
196994
16 December 2009
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Vipul Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sonia Kansal | Whole-Time Director | 08 Aug 2017 | Current |
| Parvinder Kansal | Whole-Time Director | 16 Dec 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Mar 2012 | Past |
| Pramod Abcsdd | Director | 15 Sep 2011 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2017 | Past |
| Pramod Abcsdd | Whole-Time Director | 21 Sep 2017 | Past |
| Pramod Abcsdd | Director | 28 Sep 2017 | Past |
| Pramod Abcsdd | Director | 02 Nov 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vipul Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.39% decrease. The company also saw a substantial fall in profitability, with a 52.76% decrease in profit. The company's net worth moved up by a moderate rise of 5.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Vipul Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹30,000,000.00
₹65,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2020 | Others | ₹3.00 Cr | Open |
| 05 Nov 2018 | Hdfc Bank Limited | ₹2.00 Cr | Satisfied |
| 20 Apr 2017 | Yes Bank Limited | ₹3.00 Cr | Satisfied |
| 21 Jul 2016 | Indian Bank | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vipul Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vipul Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vipul Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vipul Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Vipul Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
A charge with Others amounted to Rs. 30.00 M with Charge ID 100359253 was registered on 07 Aug 2020. was recorded as a recent event.
Progress on A charge registered on 20 Apr 2017 via Charge ID 100132022 with Yes Bank Limited was fully satisfied on 11 Jun 2020. was documented.
Progress on A charge registered on 05 Nov 2018 via Charge ID 100220944 with Hdfc Bank Limited was fully satisfied on 12 Feb 2020. was documented.
A charge with Yes Bank Limited of Rs. 30.00 M registered on 20 Apr 2017 with Charge ID 100132022 was modified on 16 Feb 2019. was recorded as a recent event.
The CIN of Vipul Pharma Private Limited is U24232DL2009PTC196994.
Vipul Pharma Private Limited is headquartered at Unit No.805, Klj Tower Netaji Subhash Place Pitampura, Delhi, Delhi, 110034.
Vipul Pharma Private Limited was incorporated on 16 December 2009.
The current directors of Vipul Pharma Private Limited are
The primary industry of Vipul Pharma Private Limited is Manufacturing.
Vipul Pharma Private Limited is unlisted.
The authorized capital of Vipul Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Vipul Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX